A randomized, double-blind, placebo controlled, multicenter, parallel-group study to assess the efficacy and safety of topiramate OROS controlled-release in the treatment of obese, type 2 diabetic subjects managed with diet or metformin.
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2007
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Jul 2007 Status change
- 19 Nov 2005 New trial record.